Signaling via the transcriptionally regulated activin receptor 2B is a novel mediator of neuronal cell death during chicken ciliary ganglion development  by Koszinowski, S. et al.
Int. J. Devl Neuroscience 41 (2015) 98–104
Contents lists available at ScienceDirect
International Journal of Developmental Neuroscience
journa l homepage: www.e lsev ier .com/ locate / i jdevneu
Signaling via the transcriptionally regulated activin receptor 2B is
a novel mediator of neuronal cell death during chicken
ciliary ganglion development
S. Koszinowskia,b,∗, K. Bussa, K. Kaehlckea, K. Krieglsteina,∗∗
a Department of Molecular Embryology, Institute of Anatomy and Cell Biology, Albert-Ludwigs-University Freiburg, D-79104 Freiburg, Germany
b Faculty of Biology, Albert-Ludwigs-University Freiburg, Schaenzlestrasse 1, D-79104 Freiburg, Germany
a r t i c l e i n f o
Article history:
Received 10 January 2015
Received in revised form 30 January 2015
Accepted 31 January 2015
Available online 3 February 2015
Keywords:
TGF-
Activin
BMP
Ontogenetic cell death
Apoptosis
Ciliary ganglion
a b s t r a c t
The TGF- ligand superfamily members activin A and BMP control important aspects of embryonic neu-
ronal development and differentiation. Both are known to bind to activin receptor subtypes IIA (ActRIIA)
and IIB, while in the avian ciliary ganglion (CG), so far only ActRIIA-expression has been described. We
show that the expression of ACVR2B, coding for the ActRIIB, is tightly regulated during CG development
and the knockdown of ACVR2B expression leads to a deregulation in the execution of neuronal apoptosis
and therefore affects ontogenetic programmed cell death in vivo. While the differentiation of choroid
neurons was impeded in the knockdown, pointing toward a reduction in activin A-mediated neural dif-
ferentiation signaling, naturally occurring neuronal cell death in the CG was not prevented by follistatin
treatment. Systemic injections of the BMP antagonist noggin, on the other hand, reduced the number of
apoptotic neurons to a similar extent as ACVR2B knockdown. We therefore propose a novel pathway in
the regulation of CG neuron ontogenetic programmed cell death, which could be mediated by BMP and
signals via the ActRIIB.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The transforming growth factor (TGF)- superfamily, compris-
ing TGF-s, bone morphogenetic proteins (BMPs), activins and
related proteins, is a key regulator of various developmental pro-
cesses in the nervous system, including the proliferation of neural
precursors, neuronal differentiation and ontogenetic programmed
cell death (Böttner et al., 2000; Unsicker and Krieglstein, 2002).
While TGF-s are established regulators of neuronal apoptosis
(Krieglstein et al., 2002), the role of activins in cell growth inhibi-
tion and apoptosis havemostly been shown in non-neural systems,
such as the immune system and carcinogenesis (Shav-Tal and
Zipori, 2002; Chen et al., 2006). In the nervous system, activins are
rather known to promote neuronal survival and regeneration after
trauma, as seen inmodels of cerebral ischemia and excitotoxic neu-
rodegeneration (Mukerji et al., 2007; Abdipranoto-Cowley et al.,
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2009)aswell asneuronaldifferentiation (Rodríguez-Martínezet al.,
2012). Nevertheless, in the oligodendroglial progenitor cell line
OLI-neu, activinAcanmediate apoptosis, in apathwaydistinct from
TGF-1-induced cell death (Schulz et al., 2008). BMPs are expressed
in the nervous system throughout development and exert pivotal
functions, starting from the induction of the neuroectoderm and
the neural crest, giving rise to the peripheral nervous system, via
the induction of dorsal cell types in the neural tube, to cell fate
regulation in the postnatal and adult brain (Hegarty et al., 2013).
Apart fromneural crest induction, BMP signaling also promotes the
onset ofneural crest cellmigrationandcanmediate apoptosis in the
rhombencephalic neural crest (Grahamet al., 1994; Sela-Donenfeld
and Kalcheim, 1999).
All TGF- family members bind to type II receptors that recruit
the type I cell surface receptors with serine/threonine kinase activ-
ity and mediate their effects via the canonical Smad signaling
pathway (Böttner et al., 2000). Activins bind to the activin recep-
tors (ActR) type IIA or IIB and recruit ActRIA/B. BMPs are also
known to bind ActRIIA/B, but other than activin signaling, which
recruits receptor Smads 2 and 3, BMPs signal via Smads 1, 5 and
8 (Krieglstein et al., 2011). In the chicken ciliary ganglion (CG), a
classical model for the study of ontogenetic neuronal programmed
cell death (Dryer, 1994), ActRIIA mRNA has been detected in CG
http://dx.doi.org/10.1016/j.ijdevneu.2015.01.006
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neuronsduringdevelopment (Kos andCoulombe, 1997) andactivin
A, produced by the choroid tissue, has been shown to induce
somatostatin/cortistatin expression in the choroid neuron popu-
lation of the ganglion (Darland et al., 1995; Nishi et al., 2010). In a
genome-wide transcriptomic screen, performed between embry-
onic day (E) 6 and E14 in the chicken CG, we have recently detected
that the transcription of the ACVR2B gene, coding for ActRIIB, is
dynamically regulated, with a signiﬁcant up-regulation of ACVR2B
expression at E7, an early stage of development prior to ontoge-
netic cell death (Landmesser and Pilar, 1974), and a fast decline
thereafter. In mice and rats, neuronal cell death peaks around
E10–E18, but still continues in the postnatal period (Lossi and
Merighi, 2003). In the human fetus, apoptotic cell death that coin-
cides with neuronal differentiation and synaptogenesis increases
around midgestation and lasts until late gestation (Chan et al.,
2002), while around birth, a stable number of cortical neurons is
achieved (Rabinowicz et al., 1996). The incubation period of the
chicken is 21 days and neuronal programmed cell death in the CG
is completed within the course of seven days until E14, and there-
fore longbeforehatching (Dryer, 1994),making theCGanattractive
model for the study of cell death.
We thus set out to elucidate the role of ACVR2B expression in
CG neuronal development, investigating its function in neuronal
differentiation and ontogenetic cell death.
2. Materials and methods
2.1. Embryos, ﬁxation and histology
Fertilized white leghorn chicken eggs (Gallus gallus domesti-
cus) were obtained from a local farm and incubated at 38.5 ◦C and
70% humidity. Embryos were staged according to Hamburger and
Hamilton (Hamburger and Hamilton, 1992). At the desired stage,
embryos were killed by decapitation and the heads were ﬁxed in
4% paraformaldehyde, dehydrated in ascending ethanol concentra-
tions and embedded in parafﬁn. 10m microtome sections were
collected for hematoxylin eosin (HE) staining, immunohistochem-
istry and in situ hybridization. In order to be able to compare
equivalent cross-sections of the ganglion, sections were consecu-
tively mounted in a series of ten slides, each comprising 4–5 single
sections covering the entire ganglion. Neurons were counted on HE
stainings as described before (Oppenheim et al., 1989).
2.2. Immunohistochemistry
Sections were deparafﬁnized and heated in citrate buffer for
improved antigen retrieval and further incubated with anti-islet-
1/2 (40.2D6) 1:50; anti-gag (AMV3C2, 1:200; both antibodies
from Developmental Studies Hybridoma Bank, University of Iowa),
anti-somatostatin (Millipore; 1:100); anti-BrdU (Sigma; 1:1000);
anti-active caspase 3 (R&D Systems, Wiesbaden, Germany; 1:500)
and visualized using biotinylated secondary antibodies (donkey-
anti-mouse; -anti-rabbit; -anti-rat; 1:100; Dianova, Hamburg,
Germany) and diaminobenzidine (Vectastain Peroxidase ABC-kit
6100, Vector Laboratories, CA, USA). Active caspase-3 and BrdU-
positive neurons were counted, taking every cell into account
showing the dark DAB precipitate. Every tenth cross-section of
the entire ganglion was counted and the mean number of positive
neurons/section was calculated.
2.3. In situ hybridization
Sections were deparafﬁnized and in situ hybridization and
preparation of the digoxigenin-labeled probes for Cash1 and
ACVR2B were performed as described previously (Ernsberger et al.,
1997). The Cash1 probe was generously provided by K. Huber
(Institute ofAnatomy,Albert LudwigsUniversity Freiburg). Chicken
ACVR2B was obtained as a chicken EST clone (ChEST296F4) from
theEST libraryof theUniversity ofManchester,UK (Boardmanet al.,
2002).
2.4. Microarray
Ciliary ganglia were dissected from E6 to 10 and E14 chicken
embryos. For each analyzed time point, ganglia from at least
40 embryos were pooled for RNA extraction using the Qia-
gen RNeasy micro kit (Qiagen, Hilden, Germany) according to
manufacturer’s instructions. Four replicate sample of each time
point were obtained. For transcriptome analysis, 4×44K Agi-
lent (Santa Clara, CA, USA) whole transcriptome arrays were
used. The raw intensity reads for each array were background
corrected by spatial detrending and subsequently quantile nor-
malized for comparison across arrays using the limma package
from Bioconductor (http://www.bioconductor.org). Probes with
low interquartile range across arrays and probes with low inten-
sities were ﬁltered out. Subsequent analysis considered only genes
having a corresponding EntrezID annotation. If multiple probes
mapped to the same EntrezID, the probe having the largest
interquartile range was chosen and all others discarded, leaving
13,533 transcripts for analysis.
2.5. Production of shRNA virus
RCAS(BP)B virus carrying an shRNA construct against ACVR2B
was produced according to (Das et al., 2006). The primers used
for the ACVR2B hairpin in the cloning oligos were shACVR2B for-
ward: gagaggtgctgctgagcgggacgtcttgctgaagaacgacttagtgaagccaca-
gatgta and sh ACVR2B reverse: attcaccaccactaggcaaacgtcttgctgaa-
gaacgacttacatctgtggcttcact. DF-1 cells were transfected with the
RCAS(BP)B sh ACVR2B plasmids and RCAS(BP)B plasmids with-
out an shRNA insert using Lipofectamine 2000 (Invitrogen, Life
Technologies, Darmstadt, Germany). Virus was concentrated from
the culture medium using Amicon ultra-4 centrifugal ﬁlter units
(MerckMillipore,Darmstadt,Germany)witha100kDacutoff. Virus
stock aliquots were stored at −20◦ until use.
2.6. Injection into chick embryos
For virus injection, eggs were incubated until the desired stage
(HH9). Virus stock was mixed with a vital dye (Fast Green, Sigma)
and backﬁlled into a glass capillary, prepared in a Flaming/Brown
micropipette puller (Shutter Instruments Co., USA). The virus was
injected into the neural tube of the embryo at the level of the
mesencephalon, where the progenitors of the CG neurons will
delaminate (Narayanan and Narayanan, 1978). The eggs were fur-
ther incubated and the embryos were sacriﬁced by decapitation
at E14. BrdU injections were performed according to (Striedter
and Keefer, 2000), shortly, BrdU (Sigma) was injected at a concen-
tration of 20g/l into one of the embryoı´s vitelline veins. The
embryos were further incubated for 3h before ﬁxation at E7 and
E9. Recombinant noggin and follistatin (SRP4675, SRP3045, Sigma)
were injected into a vitelline vein once every day between E6 and
E8 at a concentration of 0.2g/l. Embryos were ﬁxed at E9 and
processed for active caspase 3 staining.
2.7. Statistics
Data are expressed as means + SEM. Two-group analysis was
performedusing Student’s t-test. P values formultiple comparisons
were calculated using repeated measure one-way ANOVA with
Dunnett’s multiple comparisons post-hoc test. Values of p<0.05
were considered as statistically signiﬁcant. All statistical analyses
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Fig. 1. ACVR2B expression during CG development. (A) During development, the
number of CG neurons is steadily reduced between E7 and E14 (n(E7–14) =4). (B)
The number of neurons positive for active caspase-3 staining peaks at E9 and E10
(n(E7–14) =4). (C) Gene expression levels of ACVR2B as detected in the microarray.
The expression of ACVR2B is highest at E6 and E7 and constantly declines from E8
to E14. (****p<0.0001).
were performed using the GraphPad Prism6 software (GraphPad
Software Inc.).
3. Results
During the development of the CG, the number of neurons is
steadily reduced between E7 and E14 (Fig. 1A). During this time,
neurons undergoing ontogenetic programmed cell death can be
detected by active caspase-3 staining. Fig. 1B shows that the peak
of apoptotic cell death in the ganglion can be detected at E9 and
E10, where the largest number of neurons shows an apoptotic phe-
notype. In the transcriptome screen of CG neuronal development,
we observed a dynamic regulation of ACVR2B expression with the
highest level of expression at E6–E7 (p=1.5−12; 6-fold change vs.
E14) (Fig. 1C).
We then attempted to knock down the expression of ACVR2B
during CG neuron development using virus-mediated RNAi to
investigate the function of ACVR2B up-regulation prior to the
execution of ontogenetic cell death in the CG. To this end, we
constructed RCAS(BP)B virions, carrying an shRNA insert against
ACVR2B, according to (Das et al., 2006) and injected Hamilton-
Hamburger stage 9 (Hamburger and Hamilton, 1992) chicken
embryoswith the concentrated virus solution into the lumen of the
neural tube. Precursors of CG neurons delaminate from the neural
crest at this stage (Narayanan and Narayanan, 1978). After injec-
tion with the RCAS virus, the viral gag protein could be detected
in all neurons of the ganglion until E14 (Fig. 2A,b), while gag
staining was consistently absent in the control group (Fig. 2A,a).
Neuronal localization of the gag staining was corroborated by Islet-
1 immunoreactivity on adjacent sections (Fig 2A,c–d). Neurons
infected with RCAS(BP) BshACVR2B showed decreased expression
levels of ACVR2B mRNA at E7, where the in situ signal is most
prominent in the wild type control (Fig. 2A,e–f). The number of
neurons at E14, after the period of natural ontogenetic cell death
(Landmesser and Pilar, 1974), was signiﬁcantly increased (150.5%)
after ACVR2B knockdown, while neuron number after an infection
with RCAS(BP)B without shRNA insert (RCASB CTL) did not differ
from the control (Fig. 2B).
Active caspase-3 staining, detecting apoptotic neurons,wasper-
formed at E7, 9, 12 and 14. At E9, where the number of apoptotic
neurons peaks in the wild type ganglion (Fig. 1B), the knockdown
of ACVR2B led to a signiﬁcant decrease in apoptotic neuron num-
ber, while at E7, 12 and 14 there was no difference between the
knockdown and the control (Fig. 3A). Therefore, the increase in the
number of CG neurons at E14 after ACVR2B knockdown is most
likely due to a reduction in ontogenetic cell death. This notion was
further supported by the ﬁnding that the number of proliferating
cells within the ganglion is not altered by the knockdown. Embryos
were injected with BrdU at E7 and E9 according to (Striedter and
Keefer, 2000) and incubated for an additional time of 3h. The con-
secutive BrdU staining revealed similar numbers of cells that had
incorporated BrdU in the wild type and after ACVR2B knockdown
(Fig. 3B).
Since activin A is a neurodifferentiation factor in the CG and
induces somatostatin expression in the choroid neuron popula-
tion of the ganglion (Darland et al., 1995), the differentiation state
of CG neurons after ACVR2B knockdown was investigated. In situ
hybridization against Cash1, the chicken achaete scute homolog 1,
revealed an increased number of Cash1-positive neurons at E14
after ACVR2B knockdown (Fig. 4A). Precisely, Cash1-positive neu-
ron number was increased to 161.7%, and therefore comparable to
the overall increase in CG neuron number after the knockdown.
This increase in Cash1-positive neuron number could be easily
recognized on Cash1-stained sections, moreover, the Cash1-signal
was also more intense after ACVR2B knockdown (Fig. 4C,a and b)
At the same time, the number of neurons showing somatostatin-
like immunoreactivity (SOM-LIR) was comparable to the control
(Fig. 4A). Comparing the ratio of the entire number of neurons to
SOM-LIRpositiveneurons, theCGapparentlyhouses fewerneurons
with a mature choroid phenotype after ACVR2B knockdown. While
in the control, half of the neurons at E14 show SOM-LIR (49.8%),
only 40% of the neurons can be identiﬁed as choroid neurons by
their SOM-LIR after knockdown of ACVR2B (Fig. 4B). Thus, there
is a tendency toward reduction in the number of mature choroid
neurons after the knockdown, although it does not reach statistical
signiﬁcance (p=0.0864). Both the localization and staining inten-
sity of the somatostatin-like signal in the ACVR2B knockdown was
comparable to the wild type (Fig. 4C, c and d). According to liter-
ature, neurons showing SOM-LIR were most frequently located in
the ganglion periphery (Coulombe and Nishi, 1991).
To investigate whether the effects of ACVR2B knockdown are
associated with a lack of activin A or BMP-signaling, we system-
ically injected chicken embryos with either noggin or follistatin
daily from E6–8, attempting to mirror the effect of the receptor
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Fig. 2. Virus-mediated knockdown of ACVR2B during CG development leads to an increase in neuron number. (A) After the injection of RCASBshACVR2B, viral gag-protein is
detected in all neurons of the ganglion in the injected embryos until E14. Representative pictures show the uninfected wild type control (a) and the virus-infected ganglion
(b). Islet1/2 staining on consecutive sections identiﬁes all neurons of the ganglion (c and d). After virus-infection, ACVR2B mRNA levels are severely reduced (f) as compared
to the wild type expression level (e) (scale bar =50m). (B) The number of CG neurons at E14 is increased after knockdown of ACVR2B. (n(CTL) =3; n(RCASB CTL) =3;
n(RCASBshACVR2B) =7; *p=0.017). The infection with RCASB virus without shRNA construct (RCASB CTL) does not affect the number of neurons. CTL = control.
knockdown. The embryoswere then ﬁxed at E9 and active caspase-
3 positive neurons were counted. Follistatin injection did not alter
the number of apoptotic neurons, while noggin injection led to a
signiﬁcant decrease in apoptosis (Fig. 5).
4. Discussion
During development, the neuronal population of the CG under-
goes ontogenetic programmed cell death in a synchronized fashion
(Landmesser and Pilar, 1974). Multiple signaling pathways jointly
control this process, and among them, TGF- superfamily signal-
ing plays a central role in the regulation of neuronal survival and
death (Dryer, 1994; Krieglstein et al., 2000; Simpson et al., 2013).
Activin A, which is secreted from the choroid vasculature, is a neu-
rodifferentiation factor for the CG, for it induces somatostatin-like
immunoreactivity (SOM-LIR) in the choroid neuron subpopulation
in vivo (Darland and Nishi, 1998). In vitro, the same is the case for
the ciliary neuron population (Darland et al., 1995). Nevertheless,
the iris and ciliary body, which are the ciliary neuron targets, pro-
duce follistatin, an inhibitor of activin A, and therefore inhibit the
expression of SOM-LIR in ciliary neurons (Darland andNishi, 1998).
BMPs produced from the dorsal aorta act on neural crest pre-
cursor cells to induce the expression of the proneural gene Cash1,
as well as the paired homeodomain proteins Phox2a and Phox2b,
which are essential for parasympathetic ganglion development
(Guillemotet al., 1993;Pattynet al., 1999;Müller andRohrer, 2002).
Moreover, BMP7 is expressed at the site of CG formation to locally
induce the derivation of neurons from migrating Schwann cell
precursors (Müller andRohrer, 2002;Dyachuket al., 2014). Overex-
pression of BMP during CG development results in an enlargement
of the ganglion at E4.5 (stage 24/25), while treatmentwith the BMP
antagonist noggin affects the differentiation of CG neurons, since
neural crest cell aggregates can be detected in the region, where
the CG forms, but these aggregates are devoid of the autonomic
markers Cash1 and Phox2b (Müller and Rohrer, 2002).
Both BMPs and activin A can bind to activin receptors type IIA
(ActRIIA) and IIB (Krieglstein et al., 2011), but so far only ActRIIA
mRNA has been detected in CG neurons (Kos and Coulombe, 1997).
We found that ActRIIB mRNA levels are dynamically regulated
during early stages of CG development and the knockdown of
ACVR2Bexpression led to an inhibitionof ontogenetic programmed
cell death, which was accompanied by a signiﬁcant increase in
neuron number at E14 and a decrease in apoptotic cell death.
Moreover, we could show that the number of neurons express-
ing Cash1 at E14 was increased to a similar extent as the overall
neuron number, implying that the phenotype of the neurons in
respect to the expression of this proneural autonomic marker was
unaffected. On the other hand, only 40% of the neurons showed
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Fig. 3. Knockdown of ACVR2B prevents ontogenetic cell death (A) After ACVR2B knockdown, the number of active caspase-3 positive neurons is signiﬁcantly reduced
during the time of ontogenetic cell death (n (WT) E7=4; E9=3; E12=3; E14=3; n(RCASBshACVR2B)E7=4; E9=5; E12=5; E14=4 *p=0.011). B) 3h after BrdU-injection, the
numbers of proliferating cells in the CG is unchanged by RCASBshACVR2B-infection. (n(WT) E7=4; E9=4; n(RCASBshACVR2B)E7=6; E9=5. (C) Representative images of
active-caspase-3 staining on WT and shACVR2B-infected CGs at E7, 9 and 14. The decrease in the number of apoptotic neurons after ACVR2B knockdown at E9 is striking.
(scale bars correspond to 50m) (D) Representative images of BrdU staining on E7 and E9 WT and knockdown CGs showing no difference in the number of BrdU-positive
cells (scale bar =50m). WT=wild type.
immunoreactivity to somatostatin/cortistatin after ACVR2B knock-
down, as opposed to the 50% choroid neurons detected in the
control. This ﬁnding suggests a subtle disruption of activin A-
mediated neurodifferentiation-promoting signaling. Nevertheless,
activin Ahas not been implicated in the regulation of PCD in the CG;
therefore the anti-apoptotic effect of ACVR2B knockdown poten-
tially adds a newquality to ActR-mediated signaling. In the nervous
system, activinAhas so far ratherbeenshowntoexertneuroprotec-
tive effects and enforce regeneration after trauma, both in rodent
models of hypoxic–ischemic cerebral injury (Lai et al., 1996; Wu
et al., 1999; Mukerji et al., 2007) and excitotoxicity (Abdipranoto-
Cowley et al., 2009) as well as during neuronal differentiation
(Rodríguez-Martínez et al., 2012). ACVR2AmRNA is stably detected
in all CG neurons during a considerable time frame (E6.5–E18) (Kos
and Coulombe, 1997), while ACVR2B expression only shows a short
peak around E6/E7. It is therefore possible that neuroprotective
properties of ActR-signaling are mediated by the receptor subtype
2A, while signaling via the 2B subtype appears to be involved in the
proper execution of cell death.
Nevertheless, the treatment with activin A antagonist follis-
tatin did not change the number of apoptotic neurons in the
present study, rather arguing for another ligandcontrolling thepro-
apoptotic signaling via ActRIIB. TGF- is a known pro-apoptotic
modulator in CG neuron development (Krieglstein et al., 2000), but
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Fig. 4. Cash1-expression and somatostatin-like immunoreactivity (SOM-LIR) after ACVR2B knockdown (A) Signiﬁcantly more neurons express Cash1 at E14 after ACVR2B
knockdown as compared to control. (n(CTL) =3; n(RCASBshACVR2B) =7; *p=0.035), while there is no signiﬁcant difference in the number of SOM-LIR+neurons. (B) After
ACVR2B knockdown, only 40% of the neurons show SOM-LIR, while in the control, 50% of the neurons show SOM-LIR as a hallmark of choroid neuron phenotype. (n(CTL) =3;
n(RCASBshACVR2B) =7; p=0.0864. (C) Representative images of Cash1 (a and b) and SOM-LIR (c and d) signal on E14 ganglia. WT=wild type, CTL = control.
Fig. 5. Systemic injection of noggin from E6 to E8 decreases the number of active
caspase-3positiveneuronsatE9whilean injectionwith follistatindoesnotaffect the
number of apoptotic neurons (n(WT CTL) =4, n(PBS CTL) =7, n(NOG) =7, n(FOL) =5;
*p(WT vs. NOG)=0.041; **p(PBS vs. NOG)=0.0054). WT=wild type, CTL = control.
TGF-s are unable to bind to ActRs and thus are unlikely candi-
dates for death-promoting signaling via ActRIIB (Tsuchida et al.,
2008; Krieglstein et al., 2011).
The ability of BMPs to bind and signal through ActRIIB offers
an alternative pathway in the regulation of CG neuron number.
Although BMP overexpression increases CG neuron number, nog-
gin treatment does not elicit an opposite effect, but rather leads
to a deregulation of neuronal differentiation in CG neuron pre-
cursors (Müller and Rohrer, 2002). We have shown that noggin
treatment resulted in the reduction of apoptotic neuron number
at E9, a phenotype similar to the one seen after ACVR2B knock-
down, making BMP the potential ligand controlling pro-apoptotic
signaling pathways through ActRIIB. In neuronal precursors, BMP
signaling can either elicit inductive responses, like increased pro-
liferation and the speciﬁcation of dorsal cell fates, or terminating
ones, such as neuronal differentiation, mitotic arrest and apopto-
sis (Panchision et al., 2001). This wide variety of responses may
be either mediated by signal modulators or different signal trans-
duction pathways (Chen and Panchision, 2007). When neuronal
precursor cells are isolated from older embryos, their response to
exogenously applied BMPproteins is apoptotic (Furuta et al., 1997).
In vivo, BMPs have been found to localize in regionswith decreased
cell proliferation and increased apoptosis, for example in the telen-
cephalic neuroectodermor rhombomere 3 and 5, and in both cases,
pro-apoptotic signaling of BMPs is mediated by the expression of
Msx proteins (Graham et al., 1994; Furuta et al., 1997). Moreover,
different Msx family members can mediate distinct BMP signaling
pathways during early and late stages of development (Liu et al.,
2004).
Whether the novel death-promoting signaling via ActRIIB is ini-
tiated by activin A or, more likely, BMP, as well as the nature of the
downstream signaling cascade remains to be elucidated. Neverthe-
less, the tight regulation of ACVR2B expression in CG neurons prior
to cell death execution underlines the developmental importance
of this pathway.
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